Literature DB >> 6954086

Particle transport onto human airway surfaces.

J Heyder.   

Abstract

Three domains can be distinguished for particle transport onto human airway surfaces: 1. thermodynamic domain. Particles are transported by diffusion. Deposition decreases with particle diameter, is independent of particle density, increases with inspiration time and should be independent of flow rate. 2. intermediate domain. Particles are transported by diffusion and gravitational sedimentation. Deposition is slightly dependent on particle diameter, particle density and flow rate and increases with inspiration time. Since particles are effectively collected by inertial impaction in the nose this domain disappears for nose-breathing. 3. aerodynamic domain. Particles are transported by gravitational sedimentation and by inertial impaction. Deposition increases with particle diameter, particle density, inspiration time and flow rate. For normal breathing this domain consists of three subdomains. 3.1. sedimentation domain. Particles aerodynamically smaller than 2 micrometers are deposited by gravitational sedimentation in the alveolar region. 3.2. impaction-sedimentation domain. Particles aerodynamically between 2 and 12 micrometers are deposited by inertial impaction in the extrathoracic airways, by gravitational sedimentation and inertial impaction in the bronchial airways and by gravitational sedimentation in the alveolar region. 3.3 impaction domain. Particles aerodynamically larger than 12 micrometers are deposited by inertial impaction predominantly in the extrathoracic and less in the bronchial airways.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954086

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  11 in total

Review 1.  Monitoring personal allergen exposure.

Authors:  T O'Meara; E Tovey
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

Review 2.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

3.  The effect of film thickness on thermal aerosol generation.

Authors:  Dan J Myers; Ryan D Timmons; Amy T Lu; Ron L Hale; Dennis W Solas; Pravin Soni; Josh D Rabinowitz
Journal:  Pharm Res       Date:  2006-12-19       Impact factor: 4.200

4.  The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.

Authors:  Yang Chen; Paul M Young; David F Fletcher; Hak Kim Chan; Edward Long; David Lewis; Tanya Church; Daniela Traini
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

Review 5.  Integrating Lung Physiology, Immunology, and Tuberculosis.

Authors:  Jordi B Torrelles; Larry S Schlesinger
Journal:  Trends Microbiol       Date:  2017-03-30       Impact factor: 17.079

6.  Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence.

Authors:  P Zanen; J W Lammers
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Pulmonary distribution of nanoceria: comparison of intratracheal, microspray instillation and dry powder insufflation.

Authors:  Ramon M Molina; Nagarjun V Konduru; Hugo Hirano; Thomas C Donaghey; Benoit Adamo; Brendan Laurenzi; Georgios Pyrgiotakis; Joseph D Brain
Journal:  Inhal Toxicol       Date:  2016-09-12       Impact factor: 2.724

Review 8.  Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.

Authors:  Ashaben Patel; Mitesh Patel; Xiaoyan Yang; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

Review 9.  Inhalation drug delivery devices: technology update.

Authors:  Mariam Ibrahim; Rahul Verma; Lucila Garcia-Contreras
Journal:  Med Devices (Auckl)       Date:  2015-02-12

10.  Ambient sulfate aerosol deposition in man: modeling the influence of hygroscopicity.

Authors:  T B Martonen; A E Barnett; F J Miller
Journal:  Environ Health Perspect       Date:  1985-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.